Glenmark, Granules shares gain after USFDA developments; check details here

Glenmark Pharmaceuticals and Granules India announced key developments in the US market, including a product launch and a regulatory milestone that strengthen their generics portfolios.

Leave a Reply

Your email address will not be published. Required fields are marked *